Part 4: Myelodysplastic syndromes— reatment of low-risk patients with the 5q deletion
Hematol., Transfus. Cell Ther. (Impr.)
; 40(3): 274-277, July-Sept. 2018.
Article
在 En
| LILACS
| ID: biblio-953839
Responsible library:
BR408.1
Localization: BR408.1
全文:
1
索引:
LILACS
主要主题:
Thalidomide
/
Myelodysplastic Syndromes
/
Erythropoietin
/
Gene Deletion
/
Lenalidomide
研究类型:
Etiology_studies
/
Guideline
/
Risk_factors_studies
限制:
Humans
语言:
En
期刊:
Hematol., Transfus. Cell Ther. (Impr.)
期刊主题:
Hematologia
/
TransfusÆo de Sangue
年:
2018
类型:
Article